Tools & Technology

The latest news on life science tools and technology in genetics, genomics, and molecular diagnostics.

Sep 21, 2022

Sophia Genetics Partners With MSK on Clinical Decision Support, Boundless Bio on ecDNA Detection

Sep 21, 2022

Propath UK, Nucleai Partner on Spatial Proteomics Panel for Immuno-Oncology

Sep 21, 2022

Tempus, Children's Oncology Group Expand Genomic Testing Access for Pediatric Cancer Patients

Sep 20, 2022

Transcriptomics Plus 'Immune Tolerance' of Normal Tissue Shows Promise in Lung Cancer Prognosis
Premium

Sep 11, 2022

Repeat Biomarker Testing Informs Next Steps for Treatment-Resistant EGFR-Mutant NSCLC Patients
Premium

Sep 11, 2022

PD-L1 Test Comparison Finds Varying Ability to ID Bladder Cancer Patients Who Benefit From Tecentriq

Sep 7, 2022

Head and Neck Cancer Treatment Targets, Biomarkers Unearthed in Cell Model Analyses

Sep 7, 2022

BostonGene, Mass General Hospital Cancer Center Form Research Alliance

Sep 7, 2022

Indivumed, CellPhenomics Partner on Cancer Drug Target Research

Sep 1, 2022

Multiple Myeloma Researchers Chip Away at Why Some Patients Relapse Quickly After CAR T-Cell Therapy
Premium

Sep 1, 2022

UPenn Studying Telehealth Impact on Timely Cancer Sequencing, Personalized Therapy in Lung Cancer
Premium

Sep 1, 2022

Mission Bio Aims to Establish Proof of Concept for Single-Cell MRD Test in AML
Premium

Sep 1, 2022

SkylineDx Gains CE-IVD Mark for Melanoma Metastasis Risk Assay

Aug 31, 2022

Oncocyte Nets $3M VA Contract for DetermaRx Lung Cancer Prognostic Test

Aug 31, 2022

Syapse, Genesis Research Partner to Offer Expanded Oncology Real-World Evidence Services

Aug 30, 2022

Thermo Fisher Scientific Obtains CE-IVD Mark for Targeted NGS Oncology Test, Analysis Software

Aug 29, 2022

Genome Insight, Ajou University Medical Center to Test WGS Use for Routine Cancer Care

Aug 24, 2022

MMRF Data Fuels Greater Understanding of Multiple Myeloma Drug Resistance, Mutational Landscape
Premium

Aug 22, 2022

Pillar Biosciences Receives China Approval for Colon Cancer Companion Diagnostic Assay

Aug 19, 2022

Sirnaomics Launches Phase I/II Trial of RNAi Therapeutic for Facial Skin Cancer Lesions